Semaglutide while breastfeeding
I know waiting sucks, but by the time you're done breast feeding there will be new GLP-1 agonists on the market, likely providing more effective or more affordable alternatives (2 passed phase 2 clinical trials this month). And if you don't like them, the competition might bring semaglutide down. Hold love, and please don't risk the baby.
Summary: GLP-1 receptor agonists are not recommended during breastfeeding due to insufficient safety data on excretion into breast milk and potential effects on nursing infants. GLP-1 medications (semaglutide, liraglutide, dulaglutide) mimic a natural hormone that regulates glucose and appetite through insulin stimulation and glucagon suppression.
Today's Posts Mark Channels Read Forum Medications and Breastfeeding Mothers Diabetic Medications The recommendations the InfantRisk Center provides are not meant to replace medical advice from your physician. The ultimate decision to breastfeed while taking medications should be based on an informed decision including available data, discussions between a mother, her physician, and the ...
GLP-1 receptor agonists , often referred to as GLP-1s , are a class of medications primarily used to treat type 2 diabetes and increasingly, for weight management. These drugs mimic the effects of the naturally occurring glucagon-like peptide-1 ( GLP-1 ) hormone, which plays a crucial role in regulating blood sugar levels and appetite.
Can You Use GLP1 Medications While Breastfeeding Here's What We Know
Let's dig into what we actually know about GLP‑1 medications and breastfeeding . GLP‑1 receptor agonists are a class of medications originally designed to help manage type 2 diabetes. These meds mimic a natural hormone that helps control blood sugar, slow digestion, and reduce appetite. Some of the most well-known GLP‑1s include:
Tirzepatide is a long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist that increases insulin sensitivity and secretion, suppresses glucagon secretion, and slows gastric emptying. On 16 April 2026 the manufacturers updated the summary of product characteristics to say:
Overview of Glp-1 Agonist Breastfeeding Forums
Information and Discussion of GLP-1 Agonist Medications and Therapies Semaglutide Tirzepatide Retatrutide Ozempic Mounjaro Wegovy Zepbound GIP Compounding...
This is the Reddit home of https://glp1forum.com We encourage free and open discussion of all GLP-1 agonists including Semaglutide, Tirzepatide, and Retatrutide, regardless of how you're obtaining it and whether for diabetes or weight loss. Please don't discuss sources in this sub; any posts discussing sources will be deleted. Visit the forum to openly discuss sources, share prices ...
Semaglutide and Breastfeeding
Semaglutide linked to sight-threatening eye condition, study results suggest Semaglutide, a glucagon-like peptide-1 receptor agonist , may be associated with increased risk of a rare eye condition, results from a large-scale retrospective study have suggested.
